BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26840961)

  • 1. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone.
    Hashmi A; Keswani NR; Kim S; Graham DY
    South Med J; 2016 Feb; 109(2):83-6. PubMed ID: 26840961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications and acute hepatotoxicity of intravenous amiodarone.
    Huang X; Yang Y; Zhu J; Gao X; Wang G; Tan H; Liang Y; Li J
    J Int Med Res; 2009; 37(6):1928-36. PubMed ID: 20146893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute hepatitis caused by intravenous amiodarone].
    Paniagua Clusells J; Arcusa Gavalda R; Goma Masip F; Pons Masanes S; Soler Masana JM
    Rev Esp Cardiol; 1996 May; 49(5):384-5. PubMed ID: 8744394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
    Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causality assessment of liver injury after chronic oral amiodarone intake.
    Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
    López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
    Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine treats intravenous amiodarone induced liver injury.
    Mudalel ML; Dave KP; Hummel JP; Solga SF
    World J Gastroenterol; 2015 Mar; 21(9):2816-9. PubMed ID: 25759554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity.
    Giannattasio F; Salvio A; Varriale M; Picciotto FP; Di Costanzo GG; Visconti M
    Ann Ital Med Int; 2002; 17(3):180-4. PubMed ID: 12402666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of population modeling to define rational monitoring of amiodarone hepatic effects.
    Pollak PT; Shafer SL
    Clin Pharmacol Ther; 2004 Apr; 75(4):342-51. PubMed ID: 15060512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hepatitis complicating intravenous amiodarone treatment.
    Agozzino F; Picca M; Pelosi G
    Ital Heart J; 2002 Nov; 3(11):686-8. PubMed ID: 12506529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction.
    Kum LC; Chan WW; Hui HH; Wong GW; Ho SS; Sanderson JE; Yu CM; Fung JW
    Clin Cardiol; 2006 Jul; 29(7):295-9. PubMed ID: 16881537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxic hepatitis after amiodarone intravenous loading.
    Rizzioli E; Incasa E; Gamberini S; Savelli S; Zangirolami A; Tampieri M; Manfredini R
    Am J Emerg Med; 2007 Nov; 25(9):1082.e1-4. PubMed ID: 18022508
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute amiodarone liver toxicity likely due to ischemic hepatitis.
    Gluck N; Fried M; Porat R
    Isr Med Assoc J; 2011 Dec; 13(12):748-52. PubMed ID: 22332445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity after intravenous amiodarone.
    Cataldi A; Gonella D; Robutti N; Siri M; Buonocore S; Odetti P
    Aging Clin Exp Res; 2008 Dec; 20(6):593-6. PubMed ID: 19179845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy.
    James PR; Hardman SM
    Heart; 1997 Jun; 77(6):583-4. PubMed ID: 9227310
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal hepatotoxicity following oral administration of amiodarone.
    Richer M; Robert S
    Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.